Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group

MLA

Yoshihiro Inamoto, et al. “Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group.” Biology of Blood and Marrow Transplantation, vol. 26, Mar. 2020, p. S353. EBSCOhost, https://doi.org/10.1016/j.bbmt.2019.12.179.

APA

Yoshihiro Inamoto, Takahiro Fukuda, Takehiko Mori, Yuta Katayama, Makoto Onizuka, Tatsuo Ichinohe, Masatomo Kuno, Satoshi Yamasaki, Yoshiko Atsuta, & Naoyuki Uchida. (2020). Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group. Biology of Blood and Marrow Transplantation, 26, S353. https://doi.org/10.1016/j.bbmt.2019.12.179

Chicago

Yoshihiro Inamoto, Takahiro Fukuda, Takehiko Mori, Yuta Katayama, Makoto Onizuka, Tatsuo Ichinohe, Masatomo Kuno, Satoshi Yamasaki, Yoshiko Atsuta, and Naoyuki Uchida. 2020. “Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group.” Biology of Blood and Marrow Transplantation 26 (March): S353. doi:10.1016/j.bbmt.2019.12.179.